Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
Den nΓ₯vΓ¦rende markedsprisen pΓ₯ Johnson & Johnson er 2Β 501,11Β kr, med et 24-timers handelsvolum pΓ₯ 58,91MΒ kr. Eiendelens markedsverdi er 6,02TΒ kr, etter en endring pΓ₯ -1.76% det siste dΓΈgnet.
Tokenisert Johnson & Johnson handles til 2Β 537,38Β kr, med en tokenisert markedsverdi pΓ₯ 4,75MΒ kr og et 24-timers handelsvolum pΓ₯ 5,83MΒ kr. Den tokeniserte eiendelen har beveget seg -2.50% i lΓΈpet av de siste 24 timene.